The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biotherapeutics Cell Line Development Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Biotherapeutics Cell Line Development market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biotherapeutics Cell Line Development market size is estimated to be worth US$ 55610 million in 2021 and is forecast to a readjusted size of USD 74230 million by 2028 with a CAGR of 4.2% during review period. In-house accounting for % of the Biotherapeutics Cell Line Development global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Transfection & Selection segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biotherapeutics Cell Line Development include Becton Dickinson & Company, Beckman Coulter, Boehringer Ingelheim Group, Catalent Inc., and CMC Biologics A/S, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biotherapeutics Cell Line Development market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Transfection & Selection
Single Cell Cloning
Market segment by Application, can be divided into
In-house
Outsource
Hybrid
Do-It-Yourself (DIY)
Market segment by players, this report covers
Becton Dickinson & Company
Beckman Coulter
Boehringer Ingelheim Group
Catalent Inc.
CMC Biologics A/S
Lonza Group Ltd.
EMD Millipore
Partec (Sysmex Corporation)
ProBioGen AG
Selexis SA
Sigma-Aldrich Co. LLC.
Sony Biotechnology Inc.
Thermo Fisher Scientific Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biotherapeutics Cell Line Development product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biotherapeutics Cell Line Development, with revenue, gross margin and global market share of Biotherapeutics Cell Line Development from 2019 to 2022.
Chapter 3, the Biotherapeutics Cell Line Development competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biotherapeutics Cell Line Development market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biotherapeutics Cell Line Development research findings and conclusion, appendix and data source.
Geographical Area
Global
The Biotherapeutics Cell Line Development market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Biotherapeutics Cell Line Development market size is estimated to be worth US$ 55610 million in 2021 and is forecast to a readjusted size of USD 74230 million by 2028 with a CAGR of 4.2% during review period. In-house accounting for % of the Biotherapeutics Cell Line Development global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Transfection & Selection segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Biotherapeutics Cell Line Development include Becton Dickinson & Company, Beckman Coulter, Boehringer Ingelheim Group, Catalent Inc., and CMC Biologics A/S, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Biotherapeutics Cell Line Development market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Transfection & Selection
Single Cell Cloning
Market segment by Application, can be divided into
In-house
Outsource
Hybrid
Do-It-Yourself (DIY)
Market segment by players, this report covers
Becton Dickinson & Company
Beckman Coulter
Boehringer Ingelheim Group
Catalent Inc.
CMC Biologics A/S
Lonza Group Ltd.
EMD Millipore
Partec (Sysmex Corporation)
ProBioGen AG
Selexis SA
Sigma-Aldrich Co. LLC.
Sony Biotechnology Inc.
Thermo Fisher Scientific Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Biotherapeutics Cell Line Development product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Biotherapeutics Cell Line Development, with revenue, gross margin and global market share of Biotherapeutics Cell Line Development from 2019 to 2022.
Chapter 3, the Biotherapeutics Cell Line Development competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Biotherapeutics Cell Line Development market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Biotherapeutics Cell Line Development research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Biotherapeutics Cell Line Development
1.2 Classification of Biotherapeutics Cell Line Development by Type
1.2.1 Overview: Global Biotherapeutics Cell Line Development Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Biotherapeutics Cell Line Development Revenue Market Share by Type in 2021
1.2.3 Transfection & Selection
1.2.4 Single Cell Cloning
1.3 Global Biotherapeutics Cell Line Development Market by Application
1.3.1 Overview: Global Biotherapeutics Cell Line Development Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 In-house
1.3.3 Outsource
1.3.4 Hybrid
1.3.5 Do-It-Yourself (DIY)
1.4 Global Biotherapeutics Cell Line Development Market Size & Forecast
1.5 Global Biotherapeutics Cell Line Development Market Size and Forecast by Region
1.5.1 Global Biotherapeutics Cell Line Development Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Biotherapeutics Cell Line Development Market Size by Region, (2017-2022)
1.5.3 North America Biotherapeutics Cell Line Development Market Size and Prospect (2017-2028)
1.5.4 Europe Biotherapeutics Cell Line Development Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Biotherapeutics Cell Line Development Market Size and Prospect (2017-2028)
1.5.6 South America Biotherapeutics Cell Line Development Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Biotherapeutics Cell Line Development Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biotherapeutics Cell Line Development Market Drivers
1.6.2 Biotherapeutics Cell Line Development Market Restraints
1.6.3 Biotherapeutics Cell Line Development Trends Analysis
2 Company Profiles
2.1 Becton Dickinson & Company
2.1.1 Becton Dickinson & Company Details
2.1.2 Becton Dickinson & Company Major Business
2.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Product and Solutions
2.1.4 Becton Dickinson & Company Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Becton Dickinson & Company Recent Developments and Future Plans
2.2 Beckman Coulter
2.2.1 Beckman Coulter Details
2.2.2 Beckman Coulter Major Business
2.2.3 Beckman Coulter Biotherapeutics Cell Line Development Product and Solutions
2.2.4 Beckman Coulter Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Beckman Coulter Recent Developments and Future Plans
2.3 Boehringer Ingelheim Group
2.3.1 Boehringer Ingelheim Group Details
2.3.2 Boehringer Ingelheim Group Major Business
2.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product and Solutions
2.3.4 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Boehringer Ingelheim Group Recent Developments and Future Plans
2.4 Catalent Inc.
2.4.1 Catalent Inc. Details
2.4.2 Catalent Inc. Major Business
2.4.3 Catalent Inc. Biotherapeutics Cell Line Development Product and Solutions
2.4.4 Catalent Inc. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Catalent Inc. Recent Developments and Future Plans
2.5 CMC Biologics A/S
2.5.1 CMC Biologics A/S Details
2.5.2 CMC Biologics A/S Major Business
2.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Product and Solutions
2.5.4 CMC Biologics A/S Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 CMC Biologics A/S Recent Developments and Future Plans
2.6 Lonza Group Ltd.
2.6.1 Lonza Group Ltd. Details
2.6.2 Lonza Group Ltd. Major Business
2.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Product and Solutions
2.6.4 Lonza Group Ltd. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Lonza Group Ltd. Recent Developments and Future Plans
2.7 EMD Millipore
2.7.1 EMD Millipore Details
2.7.2 EMD Millipore Major Business
2.7.3 EMD Millipore Biotherapeutics Cell Line Development Product and Solutions
2.7.4 EMD Millipore Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 EMD Millipore Recent Developments and Future Plans
2.8 Partec (Sysmex Corporation)
2.8.1 Partec (Sysmex Corporation) Details
2.8.2 Partec (Sysmex Corporation) Major Business
2.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product and Solutions
2.8.4 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Partec (Sysmex Corporation) Recent Developments and Future Plans
2.9 ProBioGen AG
2.9.1 ProBioGen AG Details
2.9.2 ProBioGen AG Major Business
2.9.3 ProBioGen AG Biotherapeutics Cell Line Development Product and Solutions
2.9.4 ProBioGen AG Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 ProBioGen AG Recent Developments and Future Plans
2.10 Selexis SA
2.10.1 Selexis SA Details
2.10.2 Selexis SA Major Business
2.10.3 Selexis SA Biotherapeutics Cell Line Development Product and Solutions
2.10.4 Selexis SA Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Selexis SA Recent Developments and Future Plans
2.11 Sigma-Aldrich Co. LLC.
2.11.1 Sigma-Aldrich Co. LLC. Details
2.11.2 Sigma-Aldrich Co. LLC. Major Business
2.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product and Solutions
2.11.4 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Sigma-Aldrich Co. LLC. Recent Developments and Future Plans
2.12 Sony Biotechnology Inc.
2.12.1 Sony Biotechnology Inc. Details
2.12.2 Sony Biotechnology Inc. Major Business
2.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product and Solutions
2.12.4 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Sony Biotechnology Inc. Recent Developments and Future Plans
2.13 Thermo Fisher Scientific Inc.
2.13.1 Thermo Fisher Scientific Inc. Details
2.13.2 Thermo Fisher Scientific Inc. Major Business
2.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product and Solutions
2.13.4 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biotherapeutics Cell Line Development Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Biotherapeutics Cell Line Development Players Market Share in 2021
3.2.2 Top 10 Biotherapeutics Cell Line Development Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Biotherapeutics Cell Line Development Players Head Office, Products and Services Provided
3.4 Biotherapeutics Cell Line Development Mergers & Acquisitions
3.5 Biotherapeutics Cell Line Development New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biotherapeutics Cell Line Development Revenue and Market Share by Type (2017-2022)
4.2 Global Biotherapeutics Cell Line Development Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Biotherapeutics Cell Line Development Revenue Market Share by Application (2017-2022)
5.2 Global Biotherapeutics Cell Line Development Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Biotherapeutics Cell Line Development Revenue by Type (2017-2028)
6.2 North America Biotherapeutics Cell Line Development Revenue by Application (2017-2028)
6.3 North America Biotherapeutics Cell Line Development Market Size by Country
6.3.1 North America Biotherapeutics Cell Line Development Revenue by Country (2017-2028)
6.3.2 United States Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
6.3.3 Canada Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
6.3.4 Mexico Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Biotherapeutics Cell Line Development Revenue by Type (2017-2028)
7.2 Europe Biotherapeutics Cell Line Development Revenue by Application (2017-2028)
7.3 Europe Biotherapeutics Cell Line Development Market Size by Country
7.3.1 Europe Biotherapeutics Cell Line Development Revenue by Country (2017-2028)
7.3.2 Germany Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
7.3.3 France Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
7.3.5 Russia Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
7.3.6 Italy Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biotherapeutics Cell Line Development Revenue by Type (2017-2028)
8.2 Asia-Pacific Biotherapeutics Cell Line Development Revenue by Application (2017-2028)
8.3 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region
8.3.1 Asia-Pacific Biotherapeutics Cell Line Development Revenue by Region (2017-2028)
8.3.2 China Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
8.3.3 Japan Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
8.3.4 South Korea Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
8.3.5 India Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
8.3.7 Australia Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Biotherapeutics Cell Line Development Revenue by Type (2017-2028)
9.2 South America Biotherapeutics Cell Line Development Revenue by Application (2017-2028)
9.3 South America Biotherapeutics Cell Line Development Market Size by Country
9.3.1 South America Biotherapeutics Cell Line Development Revenue by Country (2017-2028)
9.3.2 Brazil Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
9.3.3 Argentina Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biotherapeutics Cell Line Development Revenue by Type (2017-2028)
10.2 Middle East & Africa Biotherapeutics Cell Line Development Revenue by Application (2017-2028)
10.3 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country
10.3.1 Middle East & Africa Biotherapeutics Cell Line Development Revenue by Country (2017-2028)
10.3.2 Turkey Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
10.3.4 UAE Biotherapeutics Cell Line Development Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Biotherapeutics Cell Line Development Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Biotherapeutics Cell Line Development Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Biotherapeutics Cell Line Development Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Biotherapeutics Cell Line Development Revenue (USD Million) by Region (2017-2022)
Table 5. Global Biotherapeutics Cell Line Development Revenue Market Share by Region (2023-2028)
Table 6. Becton Dickinson & Company Corporate Information, Head Office, and Major Competitors
Table 7. Becton Dickinson & Company Major Business
Table 8. Becton Dickinson & Company Biotherapeutics Cell Line Development Product and Solutions
Table 9. Becton Dickinson & Company Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 11. Beckman Coulter Major Business
Table 12. Beckman Coulter Biotherapeutics Cell Line Development Product and Solutions
Table 13. Beckman Coulter Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Boehringer Ingelheim Group Corporate Information, Head Office, and Major Competitors
Table 15. Boehringer Ingelheim Group Major Business
Table 16. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product and Solutions
Table 17. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Catalent Inc. Corporate Information, Head Office, and Major Competitors
Table 19. Catalent Inc. Major Business
Table 20. Catalent Inc. Biotherapeutics Cell Line Development Product and Solutions
Table 21. Catalent Inc. Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. CMC Biologics A/S Corporate Information, Head Office, and Major Competitors
Table 23. CMC Biologics A/S Major Business
Table 24. CMC Biologics A/S Biotherapeutics Cell Line Development Product and Solutions
Table 25. CMC Biologics A/S Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Lonza Group Ltd. Corporate Information, Head Office, and Major Competitors
Table 27. Lonza Group Ltd. Major Business
Table 28. Lonza Group Ltd. Biotherapeutics Cell Line Development Product and Solutions
Table 29. Lonza Group Ltd. Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. EMD Millipore Corporate Information, Head Office, and Major Competitors
Table 31. EMD Millipore Major Business
Table 32. EMD Millipore Biotherapeutics Cell Line Development Product and Solutions
Table 33. EMD Millipore Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Partec (Sysmex Corporation) Corporate Information, Head Office, and Major Competitors
Table 35. Partec (Sysmex Corporation) Major Business
Table 36. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product and Solutions
Table 37. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. ProBioGen AG Corporate Information, Head Office, and Major Competitors
Table 39. ProBioGen AG Major Business
Table 40. ProBioGen AG Biotherapeutics Cell Line Development Product and Solutions
Table 41. ProBioGen AG Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Selexis SA Corporate Information, Head Office, and Major Competitors
Table 43. Selexis SA Major Business
Table 44. Selexis SA Biotherapeutics Cell Line Development Product and Solutions
Table 45. Selexis SA Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Sigma-Aldrich Co. LLC. Corporate Information, Head Office, and Major Competitors
Table 47. Sigma-Aldrich Co. LLC. Major Business
Table 48. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product and Solutions
Table 49. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Sony Biotechnology Inc. Corporate Information, Head Office, and Major Competitors
Table 51. Sony Biotechnology Inc. Major Business
Table 52. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product and Solutions
Table 53. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Thermo Fisher Scientific Inc. Corporate Information, Head Office, and Major Competitors
Table 55. Thermo Fisher Scientific Inc. Major Business
Table 56. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product and Solutions
Table 57. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Biotherapeutics Cell Line Development Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Biotherapeutics Cell Line Development Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Biotherapeutics Cell Line Development by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Biotherapeutics Cell Line Development Players Head Office, Products and Services Provided
Table 62. Biotherapeutics Cell Line Development Mergers & Acquisitions in the Past Five Years
Table 63. Biotherapeutics Cell Line Development New Entrants and Expansion Plans
Table 64. Global Biotherapeutics Cell Line Development Revenue (USD Million) by Type (2017-2022)
Table 65. Global Biotherapeutics Cell Line Development Revenue Share by Type (2017-2022)
Table 66. Global Biotherapeutics Cell Line Development Revenue Forecast by Type (2023-2028)
Table 67. Global Biotherapeutics Cell Line Development Revenue by Application (2017-2022)
Table 68. Global Biotherapeutics Cell Line Development Revenue Forecast by Application (2023-2028)
Table 69. North America Biotherapeutics Cell Line Development Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Biotherapeutics Cell Line Development Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Biotherapeutics Cell Line Development Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Biotherapeutics Cell Line Development Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Biotherapeutics Cell Line Development Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Biotherapeutics Cell Line Development Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Biotherapeutics Cell Line Development Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Biotherapeutics Cell Line Development Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Biotherapeutics Cell Line Development Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Biotherapeutics Cell Line Development Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Biotherapeutics Cell Line Development Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Biotherapeutics Cell Line Development Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Biotherapeutics Cell Line Development Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Biotherapeutics Cell Line Development Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Biotherapeutics Cell Line Development Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Biotherapeutics Cell Line Development Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Biotherapeutics Cell Line Development Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Biotherapeutics Cell Line Development Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Biotherapeutics Cell Line Development Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Biotherapeutics Cell Line Development Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Biotherapeutics Cell Line Development Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Biotherapeutics Cell Line Development Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Biotherapeutics Cell Line Development Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Biotherapeutics Cell Line Development Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Biotherapeutics Cell Line Development Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Biotherapeutics Cell Line Development Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Biotherapeutics Cell Line Development Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Biotherapeutics Cell Line Development Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Biotherapeutics Cell Line Development Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Biotherapeutics Cell Line Development Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Biotherapeutics Cell Line Development Picture
Figure 2. Global Biotherapeutics Cell Line Development Revenue Market Share by Type in 2021
Figure 3. Transfection & Selection
Figure 4. Single Cell Cloning
Figure 5. Biotherapeutics Cell Line Development Revenue Market Share by Application in 2021
Figure 6. In-house Picture
Figure 7. Outsource Picture
Figure 8. Hybrid Picture
Figure 9. Do-It-Yourself (DIY) Picture
Figure 10. Global Biotherapeutics Cell Line Development Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 11. Global Biotherapeutics Cell Line Development Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Biotherapeutics Cell Line Development Revenue Market Share by Region (2017-2028)
Figure 13. Global Biotherapeutics Cell Line Development Revenue Market Share by Region in 2021
Figure 14. North America Biotherapeutics Cell Line Development Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Europe Biotherapeutics Cell Line Development Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. Asia-Pacific Biotherapeutics Cell Line Development Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. South America Biotherapeutics Cell Line Development Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Middle East and Africa Biotherapeutics Cell Line Development Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Biotherapeutics Cell Line Development Market Drivers
Figure 20. Biotherapeutics Cell Line Development Market Restraints
Figure 21. Biotherapeutics Cell Line Development Market Trends
Figure 22. Becton Dickinson & Company Recent Developments and Future Plans
Figure 23. Beckman Coulter Recent Developments and Future Plans
Figure 24. Boehringer Ingelheim Group Recent Developments and Future Plans
Figure 25. Catalent Inc. Recent Developments and Future Plans
Figure 26. CMC Biologics A/S Recent Developments and Future Plans
Figure 27. Lonza Group Ltd. Recent Developments and Future Plans
Figure 28. EMD Millipore Recent Developments and Future Plans
Figure 29. Partec (Sysmex Corporation) Recent Developments and Future Plans
Figure 30. ProBioGen AG Recent Developments and Future Plans
Figure 31. Selexis SA Recent Developments and Future Plans
Figure 32. Sigma-Aldrich Co. LLC. Recent Developments and Future Plans
Figure 33. Sony Biotechnology Inc. Recent Developments and Future Plans
Figure 34. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Figure 35. Global Biotherapeutics Cell Line Development Revenue Share by Players in 2021
Figure 36. Biotherapeutics Cell Line Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 37. Global Top 3 Players Biotherapeutics Cell Line Development Revenue Market Share in 2021
Figure 38. Global Top 10 Players Biotherapeutics Cell Line Development Revenue Market Share in 2021
Figure 39. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 40. Global Biotherapeutics Cell Line Development Revenue Share by Type in 2021
Figure 41. Global Biotherapeutics Cell Line Development Market Share Forecast by Type (2023-2028)
Figure 42. Global Biotherapeutics Cell Line Development Revenue Share by Application in 2021
Figure 43. Global Biotherapeutics Cell Line Development Market Share Forecast by Application (2023-2028)
Figure 44. North America Biotherapeutics Cell Line Development Sales Market Share by Type (2017-2028)
Figure 45. North America Biotherapeutics Cell Line Development Sales Market Share by Application (2017-2028)
Figure 46. North America Biotherapeutics Cell Line Development Revenue Market Share by Country (2017-2028)
Figure 47. United States Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. Canada Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Mexico Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Europe Biotherapeutics Cell Line Development Sales Market Share by Type (2017-2028)
Figure 51. Europe Biotherapeutics Cell Line Development Sales Market Share by Application (2017-2028)
Figure 52. Europe Biotherapeutics Cell Line Development Revenue Market Share by Country (2017-2028)
Figure 53. Germany Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. France Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. United Kingdom Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Russia Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Italy Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Asia-Pacific Biotherapeutics Cell Line Development Sales Market Share by Type (2017-2028)
Figure 59. Asia-Pacific Biotherapeutics Cell Line Development Sales Market Share by Application (2017-2028)
Figure 60. Asia-Pacific Biotherapeutics Cell Line Development Revenue Market Share by Region (2017-2028)
Figure 61. China Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Japan Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South Korea Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. India Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Southeast Asia Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Australia Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. South America Biotherapeutics Cell Line Development Sales Market Share by Type (2017-2028)
Figure 68. South America Biotherapeutics Cell Line Development Sales Market Share by Application (2017-2028)
Figure 69. South America Biotherapeutics Cell Line Development Revenue Market Share by Country (2017-2028)
Figure 70. Brazil Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Argentina Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Middle East and Africa Biotherapeutics Cell Line Development Sales Market Share by Type (2017-2028)
Figure 73. Middle East and Africa Biotherapeutics Cell Line Development Sales Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Biotherapeutics Cell Line Development Revenue Market Share by Country (2017-2028)
Figure 75. Turkey Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. UAE Biotherapeutics Cell Line Development Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Methodology
Figure 79. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
